rs996347
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022073.4(EGLN3):c.357+8710A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.288 in 151,928 control chromosomes in the GnomAD database, including 6,725 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.29 ( 6725 hom., cov: 32)
Consequence
EGLN3
NM_022073.4 intron
NM_022073.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.773
Publications
6 publications found
Genes affected
EGLN3 (HGNC:14661): (egl-9 family hypoxia inducible factor 3) Enables peptidyl-proline 4-dioxygenase activity. Involved in several processes, including activation of cysteine-type endopeptidase activity involved in apoptotic process; peptidyl-proline hydroxylation to 4-hydroxy-L-proline; and response to hypoxia. Located in cytosol and nucleus. Implicated in renal cell carcinoma. Biomarker of clear cell renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.356 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EGLN3 | ENST00000250457.9 | c.357+8710A>G | intron_variant | Intron 1 of 4 | 1 | NM_022073.4 | ENSP00000250457.4 | |||
| EGLN3 | ENST00000553215.5 | c.75+8992A>G | intron_variant | Intron 1 of 4 | 1 | ENSP00000447470.1 | ||||
| EGLN3 | ENST00000487915.6 | c.4-10471A>G | intron_variant | Intron 4 of 5 | 5 | ENSP00000451316.1 |
Frequencies
GnomAD3 genomes AF: 0.288 AC: 43682AN: 151810Hom.: 6722 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
43682
AN:
151810
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.288 AC: 43694AN: 151928Hom.: 6725 Cov.: 32 AF XY: 0.281 AC XY: 20889AN XY: 74232 show subpopulations
GnomAD4 genome
AF:
AC:
43694
AN:
151928
Hom.:
Cov.:
32
AF XY:
AC XY:
20889
AN XY:
74232
show subpopulations
African (AFR)
AF:
AC:
8087
AN:
41446
American (AMR)
AF:
AC:
3342
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
973
AN:
3466
East Asian (EAS)
AF:
AC:
1243
AN:
5168
South Asian (SAS)
AF:
AC:
911
AN:
4810
European-Finnish (FIN)
AF:
AC:
3609
AN:
10498
Middle Eastern (MID)
AF:
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24470
AN:
67956
Other (OTH)
AF:
AC:
580
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1562
3125
4687
6250
7812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
840
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.